Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ArQule stock plunges as lung cancer study shelved
ArQule stock plunges as lung cancer study shelved
ArQule stock plunges as lung cancer study shelved
Submitted by
admin
on October 2, 2012 - 11:25am
Source:
Yahoo/AP
News Tags:
Arqule
lung cancer
Daiichi Sankyo
tivantinib
non-small cell lung cancer
Headline:
ArQule stock plunges as lung cancer study shelved
Do Not Allow Advertisers to Use My Personal information
